{"count": 7, "results": [{"_id": "34595852", "pmid": 34595852, "title": "Protective effect of metformin on lithium-induced nephrogenic diabetes insipidus: An experimental study in rats.", "journal": "Adv Clin Exp Med", "authors": ["Tas HI", "Sancak EB"], "date": "2021-11-01T00:00:00Z", "doi": "10.17219/acem/140403", "meta_date_publication": "2021 Nov", "meta_volume": "30", "meta_issue": "11", "meta_pages": "1185-1193", "score": 50270.688, "text_hl": "Protective effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @CHEMICAL_Lithium @CHEMICAL_MESH:D008094 @@@lithium@@@-induced @<m>DISEASE_Diabetes_Insipidus_Nephrogenic</m> @DISEASE_MESH:D018500 @@@nephrogenic diabetes insipidus@@@: An experimental study in @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Tas HI, Sancak EB. Protective effect of metformin on lithium-induced nephrogenic diabetes insipidus: An experimental study in rats. Adv Clin Exp Med. 2021 Nov;30(11):1185-1193. PMID: 34595852", "BibTeX": "@article{34595852, title={Protective effect of metformin on lithium-induced nephrogenic diabetes insipidus: An experimental study in rats.}, author={Tas HI and Sancak EB}, journal={Adv Clin Exp Med}, volume={30}, number={11}, pages={1185-1193}}"}}, {"_id": "33724959", "pmid": 33724959, "pmcid": "PMC8119225", "title": "An AMPK activator as a therapeutic option for congenital nephrogenic diabetes insipidus", "journal": "JCI Insight", "authors": ["Klein JD", "Khanna I", "Pillarisetti R", "Hagan RA", "LaRocque LM", "Rodriguez EL", "Sands JM"], "date": "2021-04-22T00:00:00Z", "doi": "10.1172/jci.insight.146419", "meta_date_publication": "2021 Apr 22", "meta_volume": "6", "meta_issue": "8", "meta_pages": "", "score": 50264.438, "text_hl": "The data from our @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ study, however, inspired us to seek a potent and orally active AMPK activator as a potential therapy for @<m>DISEASE_Diabetes_Insipidus_Nephrogenic</m> @DISEASE_MESH:D018500 @@@NDI@@@ due to @GENE_AVPR2 @GENE_12000 @@@V2R@@@ mutations. ", "citations": {"NLM": "Klein JD, Khanna I, Pillarisetti R, Hagan RA, LaRocque LM, Rodriguez EL, Sands JM. An AMPK activator as a therapeutic option for congenital nephrogenic diabetes insipidus JCI Insight. 2021 Apr 22;6(8):. PMID: 33724959", "BibTeX": "@article{33724959, title={An AMPK activator as a therapeutic option for congenital nephrogenic diabetes insipidus}, author={Klein JD and Khanna I and Pillarisetti R and Hagan RA and LaRocque LM and Rodriguez EL and Sands JM}, journal={JCI Insight}, volume={6}, number={8}}"}}, {"_id": "32924547", "pmid": 32924547, "title": "A mini-review of pharmacological strategies used to ameliorate polyuria associated with X-linked nephrogenic diabetes insipidus.", "journal": "Am J Physiol Renal Physiol", "authors": ["Mortensen LA", "Bistrup C", "Jensen BL", "Hinrichs GR"], "date": "2020-11-01T00:00:00Z", "doi": "10.1152/ajprenal.00339.2020", "meta_date_publication": "2020 Nov 1", "meta_volume": "319", "meta_issue": "5", "meta_pages": "F746-F753", "score": 50257.273, "text_hl": "Promising effects on @<m>DISEASE_Diabetes_Insipidus_Nephrogenic</m> @DISEASE_MESH:D018500 @@@NDI@@@ in preclinical studies have been demonstrated by the use of pharmacological approaches with @GENE_SCT @GENE_6343 @@@secretin@@@, @GENE_WNT5A @GENE_7474 @@@Wnt5a@@@, protein kinase A agonist, @CHEMICAL_Fluconazole @CHEMICAL_MESH:D015725 @@@fluconazole@@@, prostaglandin E2 EP2 and @GENE_PTGER4 @GENE_5734 @@@EP4@@@ agonists, statins, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and soluble prorenin receptor agonists. ", "citations": {"NLM": "Mortensen LA, Bistrup C, Jensen BL, Hinrichs GR. A mini-review of pharmacological strategies used to ameliorate polyuria associated with X-linked nephrogenic diabetes insipidus. Am J Physiol Renal Physiol. 2020 Nov 1;319(5):F746-F753. PMID: 32924547", "BibTeX": "@article{32924547, title={A mini-review of pharmacological strategies used to ameliorate polyuria associated with X-linked nephrogenic diabetes insipidus.}, author={Mortensen LA and Bistrup C and Jensen BL and Hinrichs GR}, journal={Am J Physiol Renal Physiol}, volume={319}, number={5}, pages={F746-F753}}"}}, {"_id": "27478876", "pmid": 27478876, "title": "Metformin improves urine concentration in rodents with nephrogenic diabetes insipidus.", "journal": "JCI Insight", "authors": ["Efe O", "Klein JD", "LaRocque LM", "Ren H", "Sands JM"], "date": "2016-07-21T00:00:00Z", "doi": "10.1172/jci.insight.88409", "meta_date_publication": "2016 Jul 21", "meta_volume": "1", "meta_issue": "11", "meta_pages": "", "score": 50084.418, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ improves urine concentration in rodents with @<m>DISEASE_Diabetes_Insipidus_Nephrogenic</m> @DISEASE_MESH:D018500 @@@nephrogenic diabetes insipidus@@@.", "citations": {"NLM": "Efe O, Klein JD, LaRocque LM, Ren H, Sands JM. Metformin improves urine concentration in rodents with nephrogenic diabetes insipidus. JCI Insight. 2016 Jul 21;1(11):. PMID: 27478876", "BibTeX": "@article{27478876, title={Metformin improves urine concentration in rodents with nephrogenic diabetes insipidus.}, author={Efe O and Klein JD and LaRocque LM and Ren H and Sands JM}, journal={JCI Insight}, volume={1}, number={11}}"}}, {"_id": "27534996", "pmid": 27534996, "title": "Physiological insights into novel therapies for nephrogenic diabetes insipidus.", "journal": "Am J Physiol Renal Physiol", "authors": ["Sands JM", "Klein JD"], "date": "2016-12-01T00:00:00Z", "doi": "10.1152/ajprenal.00418.2016", "meta_date_publication": "2016 Dec 1", "meta_volume": "311", "meta_issue": "6", "meta_pages": "F1149-F1152", "score": 50074.5, "text_hl": "@CHEMICAL_Clopidogrel @CHEMICAL_MESH:D000077144 @@@Clopidogrel@@@ is a @GENE_P2RY12 @GENE_64805 @@@P2Y12-R@@@ antagonist that potentiates the effect of @GENE_AVP @GENE_551 @@@vasopressin@@@ and increases @GENE_AQP2 @GENE_359 @@@AQP2@@@ abundance. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ stimulates @GENE_PRKAA1 @GENE_5562 @@@AMPK@@@ to phosphorylate and activate @GENE_AQP2 @GENE_359 @@@AQP2@@@ and UT-A1, and it increases urine concentrating ability in two @SPECIES_9989 @@@rodent@@@ models of @<m>DISEASE_Diabetes_Insipidus_Nephrogenic</m> @DISEASE_MESH:D018500 @@@NDI@@@. ", "citations": {"NLM": "Sands JM, Klein JD. Physiological insights into novel therapies for nephrogenic diabetes insipidus. Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1149-F1152. PMID: 27534996", "BibTeX": "@article{27534996, title={Physiological insights into novel therapies for nephrogenic diabetes insipidus.}, author={Sands JM and Klein JD}, journal={Am J Physiol Renal Physiol}, volume={311}, number={6}, pages={F1149-F1152}}"}}, {"_id": "29611351", "pmid": 29611351, "pmcid": "PMC5880873", "title": "Effects of sildenafil, metformin, and simvastatin on ADH-independent urine concentration in healthy volunteers", "journal": "Physiol Rep", "authors": ["Bech AP", "Wetzels JFM", "Nijenhuis T"], "date": "2018-04-01T00:00:00Z", "doi": "10.14814/phy2.13665", "meta_date_publication": "2018 Apr", "meta_volume": "6", "meta_issue": "7", "meta_pages": "e13665", "score": 50069.676, "text_hl": "Test characteristics in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group", "citations": {"NLM": "Bech AP, Wetzels JFM, Nijenhuis T. Effects of sildenafil, metformin, and simvastatin on ADH-independent urine concentration in healthy volunteers Physiol Rep. 2018 Apr;6(7):e13665. PMID: 29611351", "BibTeX": "@article{29611351, title={Effects of sildenafil, metformin, and simvastatin on ADH-independent urine concentration in healthy volunteers}, author={Bech AP and Wetzels JFM and Nijenhuis T}, journal={Physiol Rep}, volume={6}, number={7}, pages={e13665}}"}}, {"_id": "26962099", "pmid": 26962099, "title": "Metformin, an AMPK activator, stimulates the phosphorylation of aquaporin 2 and urea transporter A1 in inner medullary collecting ducts.", "journal": "Am J Physiol Renal Physiol", "authors": ["Klein JD", "Wang Y", "Blount MA", "Molina PA", "LaRocque LM", "Ruiz JA", "Sands JM"], "date": "2016-05-15T00:00:00Z", "doi": "10.1152/ajprenal.00102.2016", "meta_date_publication": "2016 May 15", "meta_volume": "310", "meta_issue": "10", "meta_pages": "F1008-12", "score": 50066.66, "text_hl": "These findings suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may be a novel therapeutic option for @<m>DISEASE_Diabetes_Insipidus_Nephrogenic</m> @DISEASE_MESH:D018500 @@@congenital NDI@@@ due to @GENE_AVPR2 @GENE_12000 @@@V2R@@@ mutations.", "citations": {"NLM": "Klein JD, Wang Y, Blount MA, Molina PA, LaRocque LM, Ruiz JA, Sands JM. Metformin, an AMPK activator, stimulates the phosphorylation of aquaporin 2 and urea transporter A1 in inner medullary collecting ducts. Am J Physiol Renal Physiol. 2016 May 15;310(10):F1008-12. PMID: 26962099", "BibTeX": "@article{26962099, title={Metformin, an AMPK activator, stimulates the phosphorylation of aquaporin 2 and urea transporter A1 in inner medullary collecting ducts.}, author={Klein JD and Wang Y and Blount MA and Molina PA and LaRocque LM and Ruiz JA and Sands JM}, journal={Am J Physiol Renal Physiol}, volume={310}, number={10}, pages={F1008-12}}"}}]}